Physician profile
John William Murphy
NPI 1740291806
$3,715.11
in general payments reported to CMS, 2019-2025
27 companies · $83.44 in 2025
The $83.44 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2020: $523 · 2021: $751 · 2022: $507 · 2023: $133 · 2024: $314 · 2025: $83.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,208.51 | 2019-2022 | |
| Seapearl East, INC | $1,035.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $206.59 | 2021-2024 | Tapestry |
| Depuy Synthes Sales INC. | $193.56 | 2019-2023 | Orthovisc |
| Stryker Corporation | $175.15 | 2019-2025 | T2 Alpha, Mako |
| Bioventus LLC | $112.59 | 2019-2025 | Durolane |
| Novo Nordisk INC | $97.05 | 2019-2023 | Wegovy |
| Smith+Nephew, INC. | $80.10 | 2020 | |
| Pfizer INC. | $79.99 | 2019-2022 | |
| Spr Therapeutics, INC | $68.03 | 2024 | Sprint Pns System |
| Abbvie INC. | $49.32 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.28 | 2020-2021 | |
| Lilly USA, LLC | $44.12 | 2022-2024 | Mounjaro |
| Davol INC. | $42.92 | 2021 | |
| Pacira Therapeutics, INC. | $30.00 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $27.44 | 2023 | |
| Orthofix Medical, INC. | $26.79 | 2024 | Physio-Stim |
| Exact Sciences Corporation | $25.23 | 2024 | Cologuard Collection Kit |
| Ossur Americas, INC. | $24.57 | 2024 | Miami J |
| Heraeus Medical, LLC. | $23.73 | 2023 | Palacos |
| Nalu Medical, INC. | $23.13 | 2024 | Nalu Neurostimulation System |
| Baxter Healthcare | $22.47 | 2022 | |
| Heron Therapeutics, INC. | $20.51 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.74 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.47 | 2019 | |
| Amgen INC. | $12.99 | 2019 | |
| Horizon Therapeutics Plc | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.